Oxidative Stress-Mediated Damage in Newborns with Necrotizing Enterocolitis: A Possible Role of Melatonin

American Journal of Perinatology

Volumn 32, Issue 10, 2015, Pages 905-909

  Marseglia, Lucia ^a   D'Angelo, Gabriella ^a   Manti, Sara ^a   Aversa, Salvatore ^a   Reiter, Russel J ^b   Antonuccio, Pietro ^a   Centorrino, Antonio ^a   Romeo, Carmelo ^a   Impellizzeri, Pietro ^a   Gitto, Eloisa ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b University of Texas Health Science Center   (United States)

Author keywords

antioxidants; free radicals; melatonin; necrotizing enterocolitis; neonates

Indexed keywords

ANTIOXIDANT; MELATONIN;

ARTICLE; ENTEROENDOCRINE CELL; HUMAN; INTESTINE EPITHELIUM CELL; INTESTINE INJURY; LIPID PEROXIDATION; NECROTIZING ENTEROCOLITIS; NEUTROPHIL; NEWBORN; NITROSATIVE STRESS; OXIDATIVE STRESS; PATHOGENESIS; PREMATURITY; PRIORITY JOURNAL; REOXYGENATION; ENTEROCOLITIS, NECROTIZING; METABOLISM;

ANTIOXIDANTS; ENTEROCOLITIS, NECROTIZING; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MELATONIN; OXIDATIVE STRESS;

EID: 84940451907     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0035-1547328     Document Type: Article

References (67)

1. Srinivasan P. S., Brandler M. D., D'Souza A. Necrotizing enterocolitis. Clin Perinatol: 2008; 35 1 251 272, x
2. Guthrie S. O., Gordon P. V., Thomas V., Thorp J. A., Peabody J., Clark R. H. Necrotizing enterocolitis among neonates in the United States. J Perinatol: 2003; 23 4 278 285
3. Neu J. Necrotizing enterocolitis: the search for a unifying pathogenic theory leading to prevention. Pediatr Clin North Am: 1996; 43 2 409 432
4. Hunter C. J., Upperman J. S., Ford H. R., Camerini V. Understanding the susceptibility of the premature infant to necrotizing enterocolitis (NEC). Pediatr Res: 2008; 63 2 117 123
5. Sodhi C. P., Neal M. D., Siggers R., et al. Intestinal epithelial Toll-like receptor 4 regulates goblet cell development and is required for necrotizing enterocolitis in mice. Gastroenterology: 2012; 143 3 708 18.e1, 5
6. Good M., Sodhi C., Siggers R., et al. Epithelial growth factor attenuates the severity of experimental necrotizing enterocolitis and inhibits toll-like receptor 4 signaling in enterocytes. E-PAS2011: 2011; 2720 2723
7. Carlisle E. M., Morowitz M. J. The intestinal microbiome and necrotizing enterocolitis. Curr Opin Pediatr: 2013; 25 3 382 387
8. Indrio F., Neu J. The intestinal microbiome of infants and the use of probiotics. Curr Opin Pediatr: 2011; 23 2 145 150
9. Kelly N., Friend K., Boyle P., et al. The role of the glutathione antioxidant system in gut barrier failure in a rodent model of experimental necrotizing enterocolitis. Surgery: 2004; 136 3 557 566
10. Okur H., Küçükaydin M., Köse K., Konta͆ O., Doʇam P., Kazez A. Hypoxia-induced necrotizing enterocolitis in the immature rat: the role of lipid peroxidation and management by vitamin E. J Pediatr Surg: 1995; 30 10 1416 1419
11. Martindale J. L., Holbrook N. J. Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol: 2002; 192 1 1 15
12. Finkel T., Holbrook N. J. Oxidants, oxidative stress and the biology of ageing. Nature: 2000; 408 6809 239 247
13. Nadler E. P., Dickinson E., Knisely A., et al. Expression of inducible nitric oxide synthase and interleukin-12 in experimental necrotizing enterocolitis. J Surg Res: 2000; 92 1 71 77
14. Halpern M. D., Holubec H., Dominguez J. A., et al. Up-regulation of IL-18 and IL-12 in the ileum of neonatal rats with necrotizing enterocolitis. Pediatr Res: 2002; 51 6 733 739
15. Ford H., Watkins S., Reblock K., Rowe M. The role of inflammatory cytokines and nitric oxide in the pathogenesis of necrotizing enterocolitis. J Pediatr Surg: 1997; 32 2 275 282
16. Nadler E. P., Stanford A., Zhang X. R., Upperman J. S., Ford H. R. IL-11 is upregulated in human NEC. Curr Surg: 2000; 57 6 639
17. Viscardi R. M., Lyon N. H., Sun C. C., Hebel J. R., Hasday J. D. Inflammatory cytokine mRNAs in surgical specimens of necrotizing enterocolitis and normal newborn intestine. Pediatr Pathol Lab Med: 1997; 17 4 547 559
18. Lee J. S., Polin R. A. Treatment and prevention of necrotizing enterocolitis. Semin Neonatol: 2003; 8 6 449 459
19. Lin P. W., Stoll B. J. Necrotising enterocolitis. Lancet: 2006; 368 9543 1271 1283
20. Henry M. C., Moss R. L. Necrotizing enterocolitis. Annu Rev Med: 2009; 60 111 124
21. Caplan M. S., Sun X. M., Hseuh W., Hageman J. R. Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis. J Pediatr: 1990; 116 6 960 964
22. Edelson M. B., Bagwell C. E., Rozycki H. J. Circulating pro- and counterinflammatory cytokine levels and severity in necrotizing enterocolitis. Pediatrics: 1999; 103 4 Pt 1 766 771
23. Guven A., Tunc T., Topal T., et al. Alpha-lipoic acid and ebselen prevent ischemia/reperfusion injury in the rat intestine. Surg Today: 2008; 38 11 1029 1035
24. Czyrko C., Steigman C., Turley D. L., Drott H. R., Ziegler M. M. The role of reperfusion injury in occlusive intestinal ischemia of the neonate: malonaldehyde-derived fluorescent products and correlation of histology. J Surg Res: 1991; 51 1 1 4
25. Vaughan W. G., Horton J. W., Walker P. B. Allopurinol prevents intestinal permeability changes after ischemia-reperfusion injury. J Pediatr Surg: 1992; 27 8 968 972, discussion 972-973
26. Slater T. F. Free-radical mechanisms in tissue injury. Biochem J: 1984; 222 1 1 15
27. Hsueh W., Caplan M. S., Qu X. W., Tan X. D., De Plaen I. G., Gonzalez-Crussi F. Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts. Pediatr Dev Pathol: 2003; 6 1 6 23
28. Xia Z., Dickens M., Raingeaud J., Davis R. J., Greenberg M. E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science: 1995; 270 5240 1326 1331
29. Harper S. J., LoGrasso P. Signalling for survival and death in neurones: the role of stress-activated kinases, JNK and p38. Cell Signal: 2001; 13 5 299 310
30. Crossthwaite A. J., Hasan S., Williams R. J. Hydrogen peroxide-mediated phosphorylation of ERK1/2, Akt/PKB and JNK in cortical neurones: dependence on Ca(2+) and PI3-kinase. J Neurochem: 2002; 80 1 24 35
31. Li C., Jackson R. M. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol Cell Physiol: 2002; 282 2 C227 C241
32. Perrone S., Tataranno M. L., Negro S., et al. May oxidative stress biomarkers in cord blood predict the occurrence of necrotizing enterocolitis in preterm infants? J Matern Fetal Neonatal Med: 2012; 25 01 128 131
33. Saugstad O. D. Mechanisms of tissue injury by oxygen radicals: implications for neonatal disease. Acta Paediatr: 1996; 85 1 1 4
34. Halliwell B., Gutteridge J. M. Free radicals in biology and medicine. 3rd ed. Oxford, United Kingdom Oxford University Press: 1999
35. Reiter R. J., Tan D. X., Osuna C., Gitto E. Actions of melatonin in the reduction of oxidative stress. A review. J Biomed Sci: 2000; 7 6 444 458
36. Miller M. J., McNeill H., Mullane K. M., Caravella S. J., Clark D. A. SOD prevents damage and attenuates eicosanoid release in a rabbit model of necrotizing enterocolitis. Am J Physiol: 1988; 255 5 Pt 1 G556 G565
37. Southard J. H., Marsh D. C., McAnulty J. F., Belzer F. O. Oxygen-derived free radical damage in organ preservation: activity of superoxide dismutase and xanthine oxidase. Surgery: 1987; 101 5 566 570
38. Nassi N., Ponziani V., Becatti M., Galvan P., Donzelli G. Anti-oxidant enzymes and related elements in term and preterm newborns. Pediatr Int: 2009; 51 2 183 187
39. Ozdemir R., Yurttutan S., Sarl F. N., et al. Antioxidant effects of N-acetylcysteine in a neonatal rat model of necrotizing enterocolitis. J Pediatr Surg: 2012; 47 9 1652 1657
40. Guven A., Gundogdu G., Uysal B., et al. Hyperbaric oxygen therapy reduces the severity of necrotizing enterocolitis in a neonatal rat model. J Pediatr Surg: 2009; 44 3 534 540
41. Guven A., Gundogdu G., Vurucu S., et al. Medical ozone therapy reduces oxidative stress and intestinal damage in an experimental model of necrotizing enterocolitis in neonatal rats. J Pediatr Surg: 2009; 44 9 1730 1735
42. Kul M., Vurucu S., Demirkaya E., et al. Enteral glutamine and/or arginine supplementation have favorable effects on oxidative stress parameters in neonatal rat intestine. J Pediatr Gastroenterol Nutr: 2009; 49 1 85 89
43. Reiter R. J., Paredes S. D., Manchester L. C., Tan D. X. Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin. Crit Rev Biochem Mol Biol: 2009; 44 4 175 200
44. Mayo J. C., Sainz R. M., Tan D. X., et al. Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages. J Neuroimmunol: 2005; 165 1-2 139 149
45. Reiter R. J., Tan D. X., Fuentes-Broto L. Melatonin: a multitasking molecule. Prog Brain Res: 2010; 181 127 151
46. Cekmez F., Cetinkaya M., Tayman C., et al. Evaluation of melatonin and prostaglandin E1 combination on necrotizing enterocolitis model in neonatal rats. Regul Pept: 2013; 184 121 125
47. Thor P. J., Krolczyk G., Gil K., Zurowski D., Nowak L. Melatonin and serotonin effects on gastrointestinal motility. J Physiol Pharmacol: 2007; 58 Suppl 6 97 103
48. Marseglia L., D'Angelo G., Manti S., et al. Melatonin and atopy: role in atopic dermatitis and asthma. Int J Mol Sci: 2014; 15 8 13482 13493
49. Kesik V., Guven A., Vurucu S., et al. Melatonin and 1400W ameliorate both intestinal and remote organ injury following mesenteric ischemia/reperfusion. J Surg Res: 2009; 157 1 e97 e105
50. Paradies G., Petrosillo G., Paradies V., Reiter R. J., Ruggiero F. M. Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J Pineal Res: 2010; 48 4 297 310
51. Reiter R. J., Gultekin F., Flores L. J., et al. Melatonin: potential utility for improving public health. TAF Prev Med Bull: 2006; 5 131 158
52. Ersoz N., Ozler M., Altinel O., et al. Melatonin prevents peritoneal adhesions in rats. J Gastroenterol Hepatol: 2009; 24 11 1763 1767
53. Kim S. H., Lee S. M. Cytoprotective effects of melatonin against necrosis and apoptosis induced by ischemia/reperfusion injury in rat liver. J Pineal Res: 2008; 44 2 165 171
54. Cuzzocrea S., Costantino G., Gitto E., et al. Protective effects of melatonin in ischemic brain injury. J Pineal Res: 2000; 29 4 217 227
55. Cetinkaya M., Alkan T., Ozyener F., Kafa I. M., Kurt M. A., Koksal N. Possible neuroprotective effects of magnesium sulfate and melatonin as both pre- and post-treatment in a neonatal hypoxic-ischemic rat model. Neonatology: 2011; 99 4 302 310
56. Guven A., Uysal B., Gundogdu G., Oztas E., Ozturk H., Korkmaz A. Melatonin ameliorates necrotizing enterocolitis in a neonatal rat model. J Pediatr Surg: 2011; 46 11 2101 2107
57. Gibbs K., Lin J., Holzman I. R. Necrotising enterocolitis: the state of the science. Indian J Pediatr: 2007; 74 1 67 72
58. Berman L., Moss R. L. Necrotizing enterocolitis: an update. Semin Fetal Neonatal Med: 2011; 16 3 145 150
59. Marseglia L., D'Angelo G., Manti S., et al. Oxidative stress-mediated aging during the fetal and perinatal periods. Oxid Med Cell Longev: 2014; 2014 358375
60. Korkmaz A., Reiter R. J., Topal T., Manchester L. C., Oter S., Tan D. X. Melatonin: an established antioxidant worthy of use in clinical trials. Mol Med: 2009; 15 1-2 43 50
61. Gitto E., Marseglia L., Manti S., et al. Protective role of melatonin in neonatal diseases. Oxid Med Cell Longev: 2013; 2013 980374
62. Marseglia L., Aversa S., Barberi I., et al. High endogenous melatonin levels in critically ill children: a pilot study. J Pediatr: 2013; 162 2 357 360
63. Fulia F., Gitto E., Cuzzocrea S., et al. Increased levels of malondialdehyde and nitrite/nitrate in the blood of asphyxiated newborns: reduction by melatonin. J Pineal Res: 2001; 31 4 343 349
64. Gitto E., Reiter R. J., Cordaro S. P., et al. Oxidative and inflammatory parameters in respiratory distress syndrome of preterm newborns: beneficial effects of melatonin. Am J Perinatol: 2004; 21 4 209 216
65. Gitto E., Romeo C., Reiter R. J., et al. Melatonin reduces oxidative stress in surgical neonates. J Pediatr Surg: 2004; 39 2 184 189, discussion 184-189
66. Gitto E., Karbownik M., Reiter R. J., et al. Effects of melatonin treatment in septic newborns. Pediatr Res: 2001; 50 6 756 760
67. Sánchez-Barceló E. J., Mediavilla M. D., Tan D. X., Reiter R. J. Clinical uses of melatonin: evaluation of human trials. Curr Med Chem: 2010; 17 19 2070 2095